[{"address1": "859 Ward Drive", "city": "Goleta", "state": "CA", "zip": "93111", "country": "United States", "phone": "805 562 0500", "website": "https://www.inogen.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.", "fullTimeEmployees": 834, "companyOfficers": [{"maxAge": 1, "name": "Mr. Kevin R. M. Smith", "age": 52, "title": "President, CEO & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 1624254, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael J. Bourque", "age": 60, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philip  Corrin", "title": "Senior Vice President of Operations & Supply Chain", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin P. Smith", "title": "General Counsel & Executive VP of Business Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer Yi Boyer", "title": "Executive VP & Chief Human Resources Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Grgoire  Ramade", "age": 53, "title": "Executive VP & Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Krishna  Jhaveri", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Andreassi", "title": "Senior Vice President of Quality & Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adrien  Mithalal", "title": "Senior Vice President of Research & Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 6, "compensationRisk": 4, "shareHolderRightsRisk": 8, "overallRisk": 5, "governanceEpochDate": 1726617600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 10.75, "open": 10.68, "dayLow": 10.41, "dayHigh": 10.79, "regularMarketPreviousClose": 10.75, "regularMarketOpen": 10.68, "regularMarketDayLow": 10.41, "regularMarketDayHigh": 10.79, "beta": 1.053, "forwardPE": -6.2321434, "volume": 277141, "regularMarketVolume": 277141, "averageVolume": 200992, "averageVolume10days": 190350, "averageDailyVolume10Day": 190350, "bid": 10.43, "ask": 10.52, "bidSize": 200, "askSize": 300, "marketCap": 248337936, "fiftyTwoWeekLow": 4.13, "fiftyTwoWeekHigh": 13.33, "priceToSalesTrailing12Months": 0.76025, "fiftyDayAverage": 10.9013, "twoHundredDayAverage": 8.174475, "currency": "USD", "enterpriseValue": 158730384, "profitMargins": -0.283, "floatShares": 19138634, "sharesOutstanding": 23719000, "sharesShort": 1023347, "sharesShortPriorMonth": 1351833, "sharesShortPreviousMonthDate": 1722384000, "dateShortInterest": 1724976000, "sharesPercentSharesOut": 0.0431, "heldPercentInsiders": 0.01788, "heldPercentInstitutions": 0.95995003, "shortRatio": 4.01, "shortPercentOfFloat": 0.0433, "bookValue": 7.909, "priceToBook": 1.3238083, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -92442000, "trailingEps": -3.97, "forwardEps": -1.68, "pegRatio": 0.03, "enterpriseToRevenue": 0.486, "enterpriseToEbitda": -4.626, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "INGN", "underlyingSymbol": "INGN", "shortName": "Inogen, Inc", "longName": "Inogen, Inc.", "firstTradeDateEpochUtc": 1392388200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "fa96a27f-f20f-370c-9058-8d08883c0d7e", "gmtOffSetMilliseconds": -14400000, "currentPrice": 10.47, "targetHighPrice": 10.0, "targetLowPrice": 10.0, "targetMeanPrice": 10.0, "targetMedianPrice": 10.0, "recommendationMean": 2.7, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 117687000, "totalCashPerShare": 4.962, "ebitda": -34312000, "totalDebt": 21438000, "quickRatio": 2.144, "currentRatio": 2.698, "totalRevenue": 326652992, "debtToEquity": 11.428, "revenuePerShare": 13.965, "returnOnAssets": -0.100030005, "returnOnEquity": -0.39986, "freeCashflow": 5534000, "operatingCashflow": 977000, "revenueGrowth": 0.061, "grossMargins": 0.42562, "ebitdaMargins": -0.10504, "operatingMargins": -0.07486, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-23"}]